Savant Capital LLC Has $850,000 Holdings in Walgreens Boots Alliance, Inc. (WBA)

Savant Capital LLC decreased its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 21.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,849 shares of the pharmacy operator’s stock after selling 2,952 shares during the quarter. Savant Capital LLC’s holdings in Walgreens Boots Alliance were worth $850,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of WBA. Waldron LP increased its position in Walgreens Boots Alliance by 67.7% in the first quarter. Waldron LP now owns 4,500 shares of the pharmacy operator’s stock worth $373,000 after buying an additional 1,816 shares in the last quarter. Webster Bank N. A. boosted its stake in shares of Walgreens Boots Alliance by 18.4% in the first quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock worth $125,000 after acquiring an additional 235 shares during the period. Nwam LLC boosted its stake in shares of Walgreens Boots Alliance by 8.5% in the first quarter. Nwam LLC now owns 3,811 shares of the pharmacy operator’s stock worth $317,000 after acquiring an additional 300 shares during the period. Alpha Cubed Investments LLC boosted its stake in shares of Walgreens Boots Alliance by 7.1% in the first quarter. Alpha Cubed Investments LLC now owns 10,641 shares of the pharmacy operator’s stock worth $884,000 after acquiring an additional 705 shares during the period. Finally, Trust Investment Advisors boosted its stake in shares of Walgreens Boots Alliance by 0.4% in the first quarter. Trust Investment Advisors now owns 13,910 shares of the pharmacy operator’s stock worth $1,155,000 after acquiring an additional 50 shares during the period. Institutional investors and hedge funds own 60.16% of the company’s stock.

A number of equities analysts have recently weighed in on the company. Royal Bank Of Canada assumed coverage on Walgreens Boots Alliance in a research note on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 price objective for the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $94.00 price objective on shares of Walgreens Boots Alliance in a research note on Saturday, September 16th. BidaskClub lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, September 12th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a research note on Thursday, September 7th. Finally, UBS AG reaffirmed a “buy” rating and issued a $96.00 price objective (down previously from $97.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, August 23rd. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $91.31.

ILLEGAL ACTIVITY WARNING: “Savant Capital LLC Has $850,000 Holdings in Walgreens Boots Alliance, Inc. (WBA)” was first reported by Markets Daily and is the property of of Markets Daily. If you are accessing this piece of content on another website, it was stolen and reposted in violation of U.S. & international copyright law. The original version of this piece of content can be viewed at https://www.themarketsdaily.com/2017/10/12/savant-capital-llc-has-850000-holdings-in-walgreens-boots-alliance-inc-wba.html.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at 68.92 on Thursday. Walgreens Boots Alliance, Inc. has a 1-year low of $68.80 and a 1-year high of $88.00. The company has a market capitalization of $73.75 billion, a price-to-earnings ratio of 17.40 and a beta of 1.25. The stock has a 50 day moving average price of $79.08 and a 200 day moving average price of $80.85.

Walgreens Boots Alliance declared that its board has approved a share repurchase plan on Thursday, June 29th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the pharmacy operator to repurchase up to 5.9% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s board believes its stock is undervalued.

In related news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the transaction, the director now directly owns 19,151 shares in the company, valued at $1,528,058.29. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 13.50% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply